Home › Metastatic Cancer › Washington › Tacoma
Metastatic Cancer clinical trials in Tacoma, WA
9 studies for Metastatic Cancer are looking for participants at sites in and around Tacoma (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Providence Regional Cancer System-Lacey, Lacey · 23 mi away
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
RecruitingPhase 3
- Research Site, Puyallup · 8 mi away
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Northwest Medical Specialties, PLLC, Tacoma
- Northwest Medical Specialties, PLLC, Gig Harbor · 8 mi away
- Northwest Medical Specialties, PLLC, Puyallup · 8 mi away
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RecruitingPhase 3
- Research Site, Tacoma
SLV-154 Treatment of Advanced Cancers
RecruitingPhase 1
- Northwest Medical Specialties, PLLC, Tacoma
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecruitingPhase 3
- MultiCare Health System, Tacoma
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RecruitingPhase 3
- MultiCare Institute for Research & Innovation, Tacoma
- MultiCare Regional Cancer Center, Gig Harbor · 8 mi away
- MultiCare Regional Cancer Center, Puyallup · 8 mi away
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
RecruitingPhase 1/2
- Northwest Medical Specialties, PLLC, Tacoma
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
RecruitingPhase 1
- Northwest Medical Specialties, Tacoma
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Tacoma
- Non-Small Cell Lung Cancer20 studies
- Breast Cancer18 studies
- Ulcerative Colitis15 studies
- Multiple Myeloma13 studies
- Prostate Cancer11 studies
- Crohn's Disease11 studies
- Colorectal Cancer9 studies
- Melanoma7 studies
- Ovarian Cancer7 studies
- Stomach Cancer6 studies
- Esophageal Cancer6 studies
- Cancer (all types)6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.